Published on:

Plaintiff’s Lawyer Calls Xarelto Clinical Trials Akin to a Science Project

There is no question that Xarelto has been linked to a lot of serious bleeding disorders, many of which resulted in death.  There are many reasons the drug has proven so dangerous to users, but a lot of the problems are result of the reportedly negligent manner in which Bayer and Janssen Pharmaceuticals performed the safety testing and informed the U.S. Food and Drug Administration (FDA) of the Results.

Pills pouring from a medication bottle

According to a recent news feature from Forbes, one plaintiff’s lawyer that handles Xarelto injury lawsuits states that these experiments were conducted in the same manner that young students would do in an elementary school science fair when making their projects. 

It should be noted that as our Boston Xarelto injury lawyers have seen, this is not different from what the makers of Pradaxa and Eliquilis have done when making their drugs.  These three drugs, along with a newer but similar one called Savaysa, are all members of a new class of drugs known as new oral anticoagulants or NAOCs.

All of these medications are used to treat one of several serious medical conditions including atrial fibrillation (Afib). Afib is classified as an irregular heartbeat not caused by a defective heart valve.  The irregular heartbeat can result in a clot, or multiple blood clots being formed in areas such as deep within the veins of the legs.  This is serious medical condition known as deep vein thrombosis (DVT).  DVTs can also form absent a patient having Afib, and these NAOCs can be used to treat that condition as well.  The reason the clots are so dangerous is because they can break free from where they form and travel through he patient’s circulatory system. If they enter the lungs, they can punch a deadly hole in the organ, known as a pulmonary embolism (PE), or they can block blood flow to the brain causing a stroke.

For many years, Warfarin (Coumadin) was the standard drug used, but these companies claimed their new drug was safer and better.  The problem was is that it is not, and if they had actually conducted safety testing and reported those results to the FDA, they would know it, and many deaths and cases of serious internal bleeding would have been avoided.

They also did not have an antidote (reversal agent) as there is with Warfarin, and they gave patients this drug, knowing it could kill them, and knowing there was nothing emergency rooms could do to stop the deadly internal bleeding disorders according to court records.  This is the basis for the many Xarelto injury lawsuits being filed in Boston and across the county. We known that these risks involved internal bleeding in the gastrointestinal system as well as in the patient’s brain, which is known as intracranial bleeding.

It also appears that the one dose fits all approach that was their main advertising claim that it was a better alternative to traditional therapies was not true, and they knew or should have known that was that was the case.  We say should have known, because if they had done the required safety testing, they would have known.

Call the Boston Law Offices of Jeffrey S. Glassman for a free and confidential appointment — 1-888-367-2900.

Additional Resources:

Xarelto Clinical Trial Likened To ‘Science Fair Project’ By Philly Malpractice Lawyer, June 29, 2016, By Nicholas Malfitano, Forbes

More Blog Entries:
FDA Announces Testosterone Meds Must Carry Broader Warning, July 7, 2014, Boston Products Liability Lawyers Blog